Keyword: St. Jude Children's Research Hospital
Mustang Bio’s stock leapt more than 400% before settling down, on the news that its gene therapy cured eight infants with “bubble boy” syndrome.
Mustang Bio is expanding its pipeline beyond CAR-T cancer treatments by licensing a gene therapy from St. Jude Children's Research Hospital.
St. Jude, Microsoft and DNAnexus have created a data-sharing and analysis platform to help accelerate pediatric cancer research.
Recent biotech discoveries include a compound that interrupts neuropathic pain and a strategy for preventing drug- or noise-induced hearing loss.
Biotech news over the last week included a reversible sealant to shore up eye injuries and a promising gene therapy for the immune disorder known as "bubble boy" disease.
Scientists at St. Jude Children’s Research Hospital found a cancer drug stops the spread of flu infection by targeting changes in cell metabolism.